Publication | Open Access

Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia

Hematological MalignancyTransplantationOncologyGemtuzumab OzogamicinAcute Myeloid LeukemiaHigh Dose ChemotherapyHematologyPharmacologyMedicineCell TransplantationMyeloid Neoplasia